tirzepatide cause death linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s Tirzepatide Matches Competitor's Cardioprotective Benefits

Amyloid & tau modulation : In mouse models of AD, GLP-1 RAs reduce amyloid oligomer levels and plaque load

Sources Lilly investor news Eli Lilly FDA drug approval process FDA.gov Related reading Retatrutide Phase 3 Results 2026: TRIUMPH Trial Tracker Living tracker of every retatrutide trial TRIUMPH-1/2/3/4/5, TRIUMPH-Outcomes, TRANSCEND-T2D-1/2, and SYNERGY-OUTCOMES Phase 3 readouts

Consistently, our study demonstrated that exogenous TGF-1 + IL-1 induced fibroblast activation, and this effect could be inhibited by liraglutide

Brand-name semaglutide includes Wegovy, which is approved for weight loss, and Ozempic, which is approved for diabetes and, while not approved for weight loss, is often prescribed off-label for this purpose

Purpose-built for physicians Reassuring findings suggest GLP-1 receptor agonists do not increase suicide risk Key takeaways: Two studies showed no association between GLP-1 receptor agonists and increased risk for suicide or suicidal thoughts